NaV1.7 as a pain target – From gene to pharmacologyIrina Vetter, Mehdi Mobli, Hana Starobova et al.|Pharmacology & Therapeutics|2016Cited by 125
Targeting different types of human meningioma and glioma cells using a novel adenoviral vector expressing GFP-TRAIL fusion protein from hTERT promoterJessica T. Li, Ferid Murad, Ka Bian et al.|Cancer Cell International|2011Cited by 13